Citation Impact
Citing Papers
Intraprostatic Androgens and Androgen-Regulated Gene Expression Persist after Testosterone Suppression: Therapeutic Implications for Castration-Resistant Prostate Cancer
2007
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
2001 Standout
Biologically active dihydropyrimidones of the Biginelli-type — a literature survey
2000 Standout
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials
2013 Standout
Finasteride in the treatment of men with androgenetic alopecia
1998
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
2005 StandoutNobel
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Effect of Testosterone Replacement Therapy on Prostate Tissue in Men With Late-Onset Hypogonadism
2006
Harmless Herbs? A Review of the Recent Literature
1998 Standout
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
Cushing's syndrome
2015 Standout
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
Organic Causes of Erectile Dysfunction in Men Under 40
2013 Standout
Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia
2000
Cancer-associated cachexia
2018 Standout
The basic biochemistry and molecular events of hormone therapy
2007
Biology of Natural Killer Cells
1989 Standout
Polymer conjugates as anticancer nanomedicines
2006 Standout
Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients
1996
Increased telomerase activity and comprehensive lifestyle changes: a pilot study
2008 StandoutNobel
Effects of Testosterone Replacement and/or Resistance Exercise on the Composition of Megestrol Acetate Stimulated Weight Gain in Elderly Men: A Randomized Controlled Trial
2002
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
2002
Androgen action and metabolism in prostate cancer
2012
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
1997
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
2002 Standout
Polycystic Ovary Syndrome
2005 Standout
ANDROGEN METABOLISM AS IT AFFECTS HAIR GROWTH IN ANDROGENETIC ALOPECIA
1996
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Expression Cloning and Characterization of Oxidative 17β- and 3α-Hydroxysteroid Dehydrogenases from Rat and Human Prostate
1997
Conformationally Controlled Electron Delocalization in n‐Type Rods: Synthesis, Structure, and Optical, Electrochemical, and Spectroelectrochemical Properties of Dicyanocyclophanes
2011 StandoutNobel
The Biology of Hair Follicles
1999 Standout
Pathological and molecular mechanisms of prostate carcinogenesis: Implications for diagnosis, detection, prevention, and treatment
2003
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices
2000 Standout
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Serum PSA and Percent Free PSA Value Changes after Antibiotic Treatment
2008
Endocrine treatment in prostate cancer
2000
Differential alterations in 5α‐reductase type 1 and type 2 levels during development and progression of prostate cancer
2004
Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice.
1979
Preparation and biological activity of tricyclic non-steroidal inhibitors of human steroid 5α-reductase
1997
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
1997 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Estrogen Receptors in the Human Male Bladder, Prostatic Urethra, and Prostate
1995
Combination of long-acting microcapsules of the D-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy: investigation in the rat prostate cancer model.
1985 Nobel
PEGylation Confers Greatly Extended Half-Life and Attenuated Immunogenicity to Recombinant Methioninase in Primates
2004
The Effects of Transdermal Dihydrotestosterone in the Aging Male: A Prospective, Randomized, Double Blind Study
2002
Cushing's syndrome
1961
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
1998 StandoutScience
X‐Linked testicular feminization in the mouse as a non‐inducible regulatory mutation of the Jacob‐Monod type
1970
Design and Synthesis of Novel α1a Adrenoceptor-Selective Antagonists. 4. Structure−Activity Relationship in the Dihydropyrimidine Series
1999
Clinical and Experimental Studies of Benign Prostatic Hyperplasia
1990
Mechanisms of Estrogen Action
2001 Standout
A role for estrogen receptor β in the regulation of growth of the ventral prostate
2001
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Binding of a 4-Methyl-4-Aza-Steroid to 5α-Reductase of Rat Liver and Prostate Microsomes
1983
Treatment of advanced male breast cancer
1981
Stabilization of 8S progesterone receptor from human prostate in the presence of molybdate ion.
1980
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Rapid Evolution of RNA Genomes
1982 StandoutScience
Studies on the pathogenesis of the pseudohermaphroditism in the mouse with testicular feminization
1972 StandoutNobel
Neonatal estrogenization of the male mouse results in urethral dysfunction.
1996
Evidence for atrophy and apoptosis in the prostates of men given finasteride.
1996
Controls of Hair Follicle Cycling
2001 Standout
Development of Increased Cytoplasmic Binding of Androgen in the Submandibular Gland of the Mouse with Testicular Feminization
1973 StandoutNobel
The pathogenesis of benign prostatic hyperplasia
1980 Standout
Progressive resistance strength training for improving physical function in older adults
2009 Standout
Evidence for Increased Cytoplasmic Androgen Binding in the Submandibular Gland of the Mouse with Testicular Feminization
1972 StandoutNobel
The Influence of Androgen Deprivation Therapy on Dihydrotestosterone Levels in the Prostatic Tissue of Patients with Prostate Cancer
2004
The Influence of Age, Alcohol Consumption, and Body Build on Gonadal Function in Men*
1980
Treatment of advanced prostatic cancer, resistant to conventional therapy with aminoglutethimide
1985
Finasteride for benign prostatic hyperplasia
2010
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Alteration in the metabolism of dihydrotestosterone in elderly men with prostate hyperplasia.
1980
Vascular Endothelial Growth Factor (VEGF) Expression in Prostate Cancer and Benign Prostatic Hyperplasia
1997
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
1999 Standout
Breast Cancer in Men
2002 Standout
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Expression and rearrangement of the alpha, beta, and gamma chain genes of the T cell receptor in cloned murine large granular lymphocyte lines. No correlation with the cytotoxic spectrum.
1986 StandoutNobel
Works of J Geller being referenced
Five-Year Follow-Up of Patientswith Benign ProstaticHyperplasia Treated withFinasteride
1995
RELATIONSHIP BETWEEN HUMAN PROSTATIC EPITHELIAL CELL PROTEIN SYNTHESIS AND TISSUE DIHYDROTESTOSTERONE LEVEL
1987
RESPONSE OF THE PLASMA 17-HYDR0XYC0RTIC0-STEROID LEVEL TO GEL-ACTH IN TUMOROUS AND NON-TUMOROUS CUSHING'S SYNDROME
1957
Effects of castration compared with total androgen blockade on tissue dihydrotestosterone (DHT) concentration in benign prostatic hyperplasia (BPH)
1987
Comparison of various hormonal therapies for prostatic carcinoma.
1983
The effect of cyproterone acetate on advanced carcinoma of the prostate.
1968
Objective remission of metastatic breast carcinoma in a male who recieved 17-alpha hydroxy progesterone caproate (delalutin).
1961
[Endocrine pathogenesis of benign prostatic hypertrophy].
1982
Medical castration with megestrol acetate and minidose of diethylstilbestrol.
1981
Clinical review: 67: Approach to chemoprevention of prostate cancer.
1995
New sensitive discovery histoculture model for growth-inhibition studies in prostate cancer and BPH
1998
Steroid levels in cancer of the prostate--markers of tumor differentiation and adequacy of anti-androgen therapy.
1979
Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.
1992
Recombinant methioninase infusion reduces the biochemical endpoint of serum methionine with minimal toxicity in high-stage cancer patients.
1998
HUMAN BENIGN PROSTATIC HYPERPLASIA.
1965
Androgen-dependent human prostatic carcinoma tumor line in nude mice. Abstr.
1978
COMPARISON OF ANDROGEN METABOLITES IN BENIGN PROSTATIC HYPERTROPHY (BPH) AND NORMAL PROSTATE
1976